As shown in Figure 2F, if the start of anti-CD8α antibody treatment was delayed to 14 days after BMT and T cell transfer, FRC numbers did not recover over the next 5 weeks in the CD8-depleted mice when compared with controls without GVHD. Here, CD8A is linked to graft versus host disease.